SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Paul Senior who wrote (33752)3/11/2010 11:23:05 AM
From: Paul Senior  Read Replies (2) of 78661
 
I'll trim my outsize ABT position now. Management has done a very good job integrating acquisitions, and maybe expensive purchase of FACT will be a winner as well. (Market participants seem to believe that: ABT stock hasn't fallen with the purchase announcement.)

I show I've made 23 purchases of ABT beginning 3/10/09 through 8/12/09. It's become one of my largest positions. With ABT's acquisition now and with ABT's sales the drug Humira apparently slowing (18% of last year's revenue), I believe I'll adjust my risk/reward balance by reducing my position.

Yahoo shows ABT with a current p/e of 15. That seems a tad high to me in today's market, but very good compared to prior years' higher numbers. Forward p/e is shown under 12, and by that, the stock would seem if not a buy, more of a buy than a sell. For me though, perhaps not worth keeping an outsize position on.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News